P1178: BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL: SAFETY AND EFFICACY RESULTS FROM THE SAFETY RUN-IN PERIOD OF THE PHASE 3 ECHELON-3 STUDY

Detalles Bibliográficos
Autores principales: Bartlett, N. L., Yasenchak, C. A., Ashraf, K. K., Harwin, W. N., Orcutt, J., Kuriakose, P., Zinzani, P. L., Mamidipalli, A., Fenton, K., Glenn, C., Nowakowski, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430074/
http://dx.doi.org/10.1097/01.HS9.0000847576.88118.d6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430074/
http://dx.doi.org/10.1097/01.HS9.0000847576.88118.d6

Ejemplares similares